Governance della spesa pharma e farmaci ad alto costo

more+
less-

Il qaudro nomativo e regolatorio italiano alla prova della governace dei farmaci innovativi ad alto costo. Serve bilanciare le esigenze di sostenibilità della spesa con la finalitò di rendere disponibili ai pazienti le terapie innovative.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Antitrust & Trade Regulation Updates, Civil Rights Updates, Constitutional Law Updates, Health Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Nicola Carmine Salerno, Independent Economist | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »